Skip to main content
logo
INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.490
+0.040 (2.76%)
At close: Apr 20, 2026, 4:00 PM EDT
1.460
-0.030 (-2.01%)
Pre-market: Apr 21, 2026, 4:00 AM EDT

INmune Bio Revenue

In the year 2025, INmune Bio had annual revenue of $50.00K with 257.14% growth.

Revenue (ttm)
$50.00K
Revenue Growth
+257.14%
P/S Ratio
792.24
Revenue / Employee
$2,381
Employees
21
Market Cap
39.61M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202550.00K36.00K257.14%
Dec 31, 202414.00K-141.00K-90.97%
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 202011.00K--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Atara Biotherapeutics120.77M
Veru Inc.16.89M
Palatin Technologies8.96M
Evaxion7.53M
CervoMed4.01M
Aligos Therapeutics2.19M
Daré Bioscience1.03M
Outlook Therapeutics205.70K
Revenue Rankings

INMB News

More News